DOCSLIB.ORG

Emergency Management of Adrenal Insufficiency in Children

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Emergency Management of Adrenal Insufficiency in Children Review J Investig Med: first published as 10.1136/jim-2019-000999 on 28 February 2019. Downloaded from Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings Bradley S Miller, 1 Sandra P Spencer,2 Mitchell E Geffner,3 Evgenia Gourgari,4 Amit Lahoti,5 Manmohan K Kamboj,2 Takara L Stanley,6 Naveen K Uli,7 Brandy A Wicklow,8 Kyriakie Sarafoglou1 For numbered affiliations see ABStract (glucose 55 mg/dL). Despite urgent fluid resus- end of article. Adrenal insufficiency (AI) remains a significant citation with 2 intravenous boluses of normal cause of morbidity and mortality in children with 1 saline and a bolus of 10% dextrose, hypoten- Correspondence to in 200 episodes of adrenal crisis resulting in death. sion persisted. Due to clinical and biochemical Dr Bradley S Miller, Department of Pediatrics, The goal of this working group of the Pediatric features suggestive of primary adrenal insuffi- University of Minnesota Endocrine Society Drug and Therapeutics Committee ciency (AI), blood was drawn for measurement Masonic Children’s Hospital, was to raise awareness on the importance of early of adrenocorticotropic hormone (ACTH) and 2450 Riverside Ave, recognition of AI, to advocate for the availability cortisol levels prior to administering 75 mg of Minneapolis, MN 55454, intravenous hydrocortisone sodium succinate USA; mille685@ umn. edu of hydrocortisone sodium succinate (HSS) on emergency medical service (EMS) ambulances or (Solu-Cortef). He was admitted and diagnosis The work has been allow EMS personnel to administer patient’s HSS confirmed. Treatment was initiated with hydro- presented at Pediatric home supply to avoid delay in administration of life- cortisone and fludrocortisone. The patient and Academic Society Meeting saving stress dosing, and to provide guidance on the family received education for the management 2018, ’Year In Review: Emergency Management emergency management of children in adrenal crisis. of primary AI and prevention of adrenal crises. of Adrenal Insufficiency in Currently, hydrocortisone, or an equivalent synthetic Two years later he developed acute gastro- Children: A Clinical Practice glucocorticoid, is not available on most ambulances enteritis with fever, vomiting and diarrhea while Guideline’, Toronto, Ontario, for emergency stress dose administration by EMS visiting his grandparents in a rural area. He Canada, May 2018. personnel to a child in adrenal crisis. At the same received triple his usual dose of oral hydrocor- Accepted 7 February 2019 time, many States have regulations preventing the tisone, but vomited within 10 minutes. Grand- use of patient’s home HSS supply to be used to parents had hydrocortisone sodium succinate treat acute adrenal crisis. In children with known AI, available for intramuscular injection, but parents and care providers must be made familiar did not know how to administer it and called http://jim.bmj.com/ with the administration of maintenance and stress 911. The patient was unresponsive on arrival of dose glucocorticoid therapy to prevent adrenal the ambulance 20 minutes later. Grandparents crises. Patients with known AI and their families informed the emergency medical technicians should be provided an Adrenal Insufficiency Action (EMT) that he needs to receive hydrocortisone Plan, including stress hydrocortisone dose (both sodium succinate intramuscularly for AI. Due oral and intramuscular/intravenous) to be provided to emergency medical services (EMS) policy, immediately to EMS providers and triage personnel the EMTs were not allowed to administer the on September 27, 2021 by guest. Protected copyright. in urgent care and emergency departments. child’s personal supply of hydrocortisone Advocacy efforts to increase the availability of stress sodium succinate and did not have an alterna- dose HSS during EMS transport care and add HSS to tive medication on the ambulance. Glucometer weight-based dosing tapes are highly encouraged. revealed a blood glucose of 30 mg/dL. While EMTs attempted to place an intravenous cath- eter, he experienced a seizure. He was intubated and received intravenous dextrose with cessa- INTRODUCTION tion of the seizure. He was transported to a © American Federation for Prismatic clinical scenario local ED that was 30 minutes away. In the ED, Medical Research 2019. A 9-year-old boy presented to a local emer- he was given 75 mg intravenous hydrocortisone Re-use permitted under gency department (ED) with chronic abdom- sodium succinate and was admitted to the inten- CC BY-NC. No commercial sive care unit where he later died of complica- re-use. Published by BMJ. inal pain, acute onset of nausea and vomiting for the previous 24 hours. Physical examina- tions related to prolonged hypoglycemia and To cite: Miller BS, tion revealed an ill-appearing, thin male with aspiration pneumonitis. Spencer SP, Geffner ME, tachycardia (pulse 110 bpm), mild hypoten- et al. J Investig Med Epub ahead of print: [please sion (85/60 mm Hg), signs of dehydration, and BacKGROUND include Day Month Year]. hyperpigmentation. Laboratory testing showed Adrenal crisis is a life-threatening condi- doi:10.1136/jim-2019- hyponatremia (sodium 129 mEq/L), hyperka- tion that can be prevented by recognition in 000999 lemia (potassium 5.8 mEq/L) and hypoglycemia which patients with AI must receive additional Miller BS, et al. J Investig Med 2019;0:1–10. doi:10.1136/jim-2019-000999 1 Review J Investig Med: first published as 10.1136/jim-2019-000999 on 28 February 2019. Downloaded from Table 1 Congenital causes of adrenal insufficiency Table 1 Continued Affected Affected Condition gene Clinical phenotype Condition gene Clinical phenotype Primary Proopiomelanocortin deficiency POMC Severe early-onset hyperphagic CAH obesity, red hair 21-α-hydroxylase deficiency CYP21A2 46,XX DSD/androgen excess; Proprotein convertase 1 PCSK1 Hypoglycemia, malabsorption, salt-wasting mutation gonadotropin deficiency 3-β-hydroxysteroid HSD3B2 Ambiguous genitalia/salt- ACTH, adrenocorticotropic hormone; CAH, congenital adrenal dehydrogenase deficiency wasting hyperplasia; CRH, corticotropin-releasing hormone; DSD, disorder of sex 11-β-hydroxylase deficiency CYP11B2 46,XX DSD/androgen excess; development; NK, natural killer. hypertension (not infants) P450 side-chain cleavage CYP11A 46,XY DSD; salt-wasting, syndrome hypogonadism glucocorticoids when under physiological stress. Adrenal Lipoid hyperplasia StAR 46,XY DSD; salt-wasting; crisis can also occur as the initial clinical presentation of AI. hypogonadism Appropriate management requires immediate recognition P450 oxidoreductase POR 46,XY DSD, salt-wasting, of the clinical signs, symptoms and biochemical profile of AI deficiency (PORD) hypogonadism, Antley-Bixler malformation; altered drug and the triggers for adrenal crisis. Therefore, primary care, metabolism urgent care and ED providers must be trained to recognize Congenital adrenal hypoplasia SF-1 46,XY DSD, gonadal the diverse clinical circumstances in which AI can occur. In (NR5A1) insufficiency children with known AI, parents and care providers must be DAX-1 Hypogonadotropic familiar with the administration of maintenance and stress (NROB1) hypogonadism dose glucocorticoid therapy to prevent adrenal crises. This CDKN1C IMAGe syndrome (intrauterine can be facilitated by providing the family with a written growth retardation, Adrenal Insufficiency Action Plan and Emergency Care metaphyseal dysplasia, genital Letter. Currently, hydrocortisone, or an equivalent synthetic anomalies) glucocorticoid, is not available on most ambulances for Triple A or Allgrove AAAS Achalasia, alacrima emergency administration by EMS personnel. In addition, Isolated familial glucocorticoid MC2R, Tall stature, normal EMT training on the use of patient’s home medication is deficiency (FGD) MRAP mineralocorticoid production not widely employed. Both of these situations can lead to FGD–DNA repair defect MCM4 NK-cell defect, short stature, life-threatening delays in providing appropriate therapy to recurrent viral infections, prevent or treat adrenal crises. microcephaly, chromosomal breakage AI is a significant cause of morbidity and mortality in chil- 1–3 Glucocorticoid resistance GCCR Mineralocorticoid/androgen dren with an annual estimated incidence of adrenal crisis excess of 5–10 episodes per 100 patient-years, with increasing 4 http://jim.bmj.com/ Metabolic diseases rates in some countries. One in every 200 episodes of 5 Adrenoleukodystrophy ABCD1 Neurologic deterioration adrenal crisis results in death. Therefore, the goal of this Zellweger PEX Cerebrohepatorenal syndrome working group was to raise awareness on the importance of Smith-Lemli-Opitz DHCR7 46,XY sex reversal, polydactyly, early recognition and provide guidance on the emergency mental retardation management of AI in children during illnesses, particularly in the outpatient, EMS and ED settings. Wolman LIPA Hepatomegaly Mitochondrial disease on September 27, 2021 by guest. Protected copyright. Kearns-Sayre Ophthalmoplegia, myopathy ETIOLOGY Secondary: hypothalamus AI is characterized by impaired adrenal synthesis of gluco- Holoprosencephaly GLI2, corticoids. When reduced production of mineralocorticoid FGF8 (aldosterone) is present it is associated with hyponatremia CRH deficiency due to salt-wasting and reciprocal hyperkalemia. AI can be Maternal hypercortisolemia categorized as primary, where the defect is in the adrenal Secondary: pituitary/hypothalamus gland, or secondary (central),
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2008/0317805 A1 Mckay Et Al
    US 20080317805A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0317805 A1 McKay et al. (43) Pub. Date: Dec. 25, 2008 (54) LOCALLY ADMINISTRATED LOW DOSES Publication Classification OF CORTICOSTEROIDS (51) Int. Cl. A6II 3/566 (2006.01) (76) Inventors: William F. McKay, Memphis, TN A6II 3/56 (2006.01) (US); John Myers Zanella, A6IR 9/00 (2006.01) Cordova, TN (US); Christopher M. A6IP 25/04 (2006.01) Hobot, Tonka Bay, MN (US) (52) U.S. Cl. .......... 424/422:514/169; 514/179; 514/180 (57) ABSTRACT Correspondence Address: This invention provides for using a locally delivered low dose Medtronic Spinal and Biologics of a corticosteroid to treat pain caused by any inflammatory Attn: Noreen Johnson - IP Legal Department disease including sciatica, herniated disc, Stenosis, mylopa 2600 Sofamor Danek Drive thy, low back pain, facet pain, osteoarthritis, rheumatoid Memphis, TN38132 (US) arthritis, osteolysis, tendonitis, carpal tunnel syndrome, or tarsal tunnel syndrome. More specifically, a locally delivered low dose of a corticosteroid can be released into the epidural (21) Appl. No.: 11/765,040 space, perineural space, or the foramenal space at or near the site of a patient's pain by a drug pump or a biodegradable drug (22) Filed: Jun. 19, 2007 depot. E Day 7 8 Day 14 El Day 21 3OO 2OO OO OO Control Dexamethasone DexamethasOne Dexamethasone Fuocinolone Fluocinolone Fuocinolone 2.0 ng/hr 1Ong/hr 50 ng/hr 0.0032ng/hr 0.016 ng/hr 0.08 ng/hr Patent Application Publication Dec. 25, 2008 Sheet 1 of 2 US 2008/0317805 A1 900 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 80.0 - 7OO – 6OO - 5OO - E Day 7 EDay 14 40.0 - : El Day 21 2OO - OO = OO – Dexamethasone Dexamethasone Dexamethasone Fuocinolone Fluocinolone Fuocinolone 2.0 ng/hr 1Ong/hr 50 ng/hr O.OO32ng/hr O.016 ng/hr 0.08 nghr Patent Application Publication Dec.
    [Show full text]
  • Congenital Adrenal Hyperplasia in the Newborn
    The Leo Fung Center for CAH and Disorders of Sex Development Congenital Adrenal Hyperplasia in the Newborn Contents Introduction 1 What is congenital adrenal hyperplasia? 1 Types of CAH 3 Diagnosing CAH in newborns 4 Treating CAH 5 Untreated CAH 7 CAH in children and young adults 8 Frequently asked questions 9 Glossary 11 Resources 13 Acknowledgments 14 Congenital Adrenal Hyperplasia in the Newborn 1 Introduction This handbook will provide you and your family information about congenital adrenal hyperplasia (CAH). While this guide will not answer all of your questions, it will provide basic medical facts that will help you to talk to your doctors. It is important to know that CAH cannot be cured but it can be treated. Your child will need to take medicine for the rest of his or her life. If your child takes this medicine, he or she should have a completely normal life in every way. Successful treatment requires teamwork between you and your doctor. The doctor will monitor your child in order to know what dose of medicine is needed. We ask that you give your baby the medication on the schedule recommended by your doctor. Your family is not alone. The Leo Fung Center for CAH and Disorders of Sex Development (DSD) at University of Minnesota Amplatz Children’s Hospital, provides a large network of support, including medical specialists, therapists and counselors who all have expertise in caring for patients with CAH. What is congenital adrenal hyperplasia? Let’s begin by examining each word. • Congenital means existing at birth (inherited). • Adrenal means that the adrenal glands are involved.
    [Show full text]
  • DOI: 10.4274/Jcrpe.Galenos.2021.2020.0175
    DOI: 10.4274/jcrpe.galenos.2021.2020.0175 Case report A novel SCNN1A variation in a patient with autosomal-recessive pseudohypoaldosteronism type 1 Mohammed Ayed Huneif1*, Ziyad Hamad AlHazmy2, Anas M. Shoomi 3, Mohammed A. AlGhofely 3, Dr Humariya Heena 5, Aziza M. Mushiba 4, Abdulhamid AlSaheel3 1Pediatric Endocrinologist at Najran university hospital, Najran Saudi Arabia. 2 Pediatric Endocrinologist at Al yamammah hospital, , Riyadh, Saudi Arabia. 3 Pediatric Endocrinologist at Pediatric endocrine department,. Obesity, Endocrine, and Metabolism Center, , King Fahad Medical City, Riyadh, Saudi Arabia. 4Clinical Geneticist, Pediatric Subspecialties Department, Children's Specialized Hospital, King Fahad Medical City, Riyadh, Saudi Arabia. 5 Research Center, King Fahad Medical City, Riyadh , Saudi Arabia What is already known on this topic ? Autosomal-recessive pseudohypoaldosteronism type 1 (PHA1) is a rare genetic disorder caused by different variations in the ENaC subunit genes. Most of these variations appear in SCNN1A mainly in exon eight, which encodes for the alpha subunit of the epithelial sodium channel ENaC. Variations are nonsense, single-base deletions or insertions, or splice site variations, leading to mRNA and proteins of abnormal length. In addition, a few new missense variations have been reported. What this study adds ? We report a novel mutation [ c.729_730delAG (p.Val245Glyfs*65) ] in the exon 4 of the SCNN1A gene In case of autosomal recessive pseudohypoaldosteronism type 1. Patient with PHA1 requires early recognition, proper treatment, and close follow-up. Parents are advised to seek genetic counseling and plan future pregnancies. proof Abstract Pseudohypoaldosteronism type 1 (PHA1) is an autosomal-recessive disorder characterized by defective regulation of body sodium levels.
    [Show full text]
  • Conduct Protocol in Emergency: Acute Adrenal Insufficiency
    ORIGINAL ARTICLE FARES AND SANTOS Conduct protocol in emergency: Acute adrenal insufficiency ADIL BACHIR FARES1*, RÔMULO AUGUSTO DOS SANTOS2 1Medical Student, 6th year, Faculdade de Medicina de São José do Rio Preto (Famerp), São José do Rio Preto, SP, Brazil 2Degree in Endocrinology and Metabology from Sociedade Brasileira de Endocrinologia e Metabologia (SBEM). Assistant Physician at the Internal Medicine Service of Hospital de Base. Researcher at Centro Integrado de Pesquisa (CIP), Hospital de Base, São José do Rio Preto. Endocrinology Coordinator of the Specialties Outpatient Clinic (AME), São José do Rio Preto, SP, Brazil SUMMARY Introduction: Acute adrenal insufficiency or addisonian crisis is a rare comor- bidity in emergency; however, if not properly diagnosed and treated, it may progress unfavorably. Objective: To alert all health professionals about the diagnosis and correct treatment of this complication. Method: We performed an extensive search of the medical literature using spe- cific search tools, retrieving 20 articles on the topic. Results: Addisonian crisis is a difficult diagnosis due to the unspecificity of its signs and symptoms. Nevertheless, it can be suspected in patients who enter the emergency room with complaints of abdominal pain, hypotension unresponsive to volume or vasopressor agents, clouding, and torpor. This situation may be associated with symptoms suggestive of chronic adrenal insufficiency such as hyperpigmentation, salt craving, and association with autoimmune diseases such as vitiligo and Hashimoto’s thyroiditis. Hemodynamically stable patients Study conducted at Faculdade may undergo more accurate diagnostic methods to confirm or rule out addiso- de Medicina de São José do nian crisis. Delay to perform diagnostic tests should be avoided, in any circum- Rio Preto (Famerp), São José do Rio Preto, SP, Brazil stances, and unstable patients should be immediately medicated with intravenous glucocorticoid, even before confirmatory tests.
    [Show full text]
  • ACUTE ADRENAL INSUFFICIENCY by PAUL FOURMAN, M.D., M.R.C.P
    Postgrad Med J: first published as 10.1136/pgmj.29.330.215 on 1 April 1953. Downloaded from 215 ACUTE ADRENAL INSUFFICIENCY By PAUL FOURMAN, M.D., M.R.C.P. Nuffield Department of Clinical Medicine, University of Oxford In acute adrenal insufficiency we are faced with common in patients whose adrenal insufficiency is the interaction of many factors ; if in trying to due to hypopituitarism than in patients with disentangle them I have cut some knots it is for Addison's disease. the sake of brevity. Addison's disease is characterized by a failure to Acute adrenal insufficiency may result from conserve sodium and we usually think of the crisis sudden loss of adrenal function by haemorrhage, of acute adrenal insufficiency as a condition of thrombosis or ablation. More often it-occurs in a shock brought about by salt depletion. This patient with chronic adrenal insufficiency, either might be true in a patient with Addison's disease in the natural course of the illness or following who is in crisis when he first presents ; in him the an injury such as'infection, operation or exposure. crisis is the climax of a long illness during which Acute adrenal insufficiency is characterized by there has been time for the sodium stores to by copyright. prostration and collapse with low blood pressure become depleted. The sodium depletion may and rapid pulse. It is usually accompanied by represent a stress that released the crisis rather gastro-intestinal symptoms: anorexia, vomiting than the immediate cause of the shock-like state. and diarrhoea, and sometimes abdominal pain and Sodium depletion is not an essential feature of hiccup.
    [Show full text]
  • Lyase Deficiency Due to P.R96W Mutation in the CYP17 Gene in a Brazilian Patient
    clinical case report Combined 17α-hydroxylase/17,20- lyase deficiency due to p.R96W mutation in the CYP17 gene in a Brazilian patient Deficiência combinada de 17α-hidroxilase/17,20 liase devido à mutação p.R96W no gene CYP17 em um paciente brasileiro Fabíola Costenaro1, Ticiana C. Rodrigues1, Claudio E. Kater2, Richard J. Auchus3, Mahboubeh Papari-Zareei3, Mauro A. Czepielewski1 SUMMARY 1 Division of Endocrinology, Congenital adrenal hyperplasia (CAH) resulting from 17α-hydroxylase/17,20-lyase deficiency is Hospital de Clínicas de Porto a rare autosomal recessive disease and the second most common form of CAH in Brazil. We Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), describe the case of a Brazilian patient with CYP17 deficiency (17α-hydroxylase/17,20-lyase de- Porto Alegre, RS, Brazil ficiency) caused by a homozygous p.R96W mutation on exon 1 of the CYP17 gene, an unusual 2 Division of Endocrinology genotype in Brazilian patients with this form of CAH. The patient, raised as a normal female, and Metabolism, Department of Medicine, Escola Paulista sought medical care for lack of pubertal signs and primary amenorrhea at the age of 16 years. At de Medicina, Universidade evaluation, the presence of a 46,XY karyotype, hypertension and hypokalemia were observed. Federal de São Paulo (Unifesp/ We emphasize the recognition of CYP17 deficiency in the differential diagnosis of cases of hy- EPM), São Paulo, SP, Brazil 3 Division of Endocrinology and pergonadotrophic hypogonadism and hypertension in young patients who need specific treat- Metabolism, Department of Internal ment for both situations. Arq Bras Endocrinol Metab. 2010;54(8):744-8 Medicine, University of Texas Southwestern Medical Center, USA SUMÁRIO Correspondence to: A hiperplasia adrenal congênita (HAC), em razão da deficiência de 17α-hidroxilase/17,20-liase, Mauro A.
    [Show full text]
  • Preventable Deaths: Panhypopituitarism and Adrenal Insufficiency
    Preventable Deaths: Panhypopituitarism and adrenal insufficiency. What you need to know What is panhypopituitarism? Your child has been diagnosed with a big scary sounding word, and all you can think is: 'What does this mean? and 'Why have I never heard of this?' Simply put, panhypopituitarism means that your child's pituitary gland does not function properly and as a result, your child is deficient in one or several hormones. Some children have congenital panhypopituitarism, meaning they are born with it. Others have acquired panhypopituitarism following an event such as head trauma, brain tumor surgery, or brain radiation. It is rare enough that is entirely possible, in fact, probable, that you will not initially know anyone else with this disorder. What will my child need? Although the diagnosis and condition can seem intimidating, it is very manageable once you understand what is needed. Unfortunately the condition cannot be cured or reversed, but again, it can be effectively managed. Your child will need to take medications to replace the missing hormones. These might include thyroid hormone, growth hormone, cortisol, and/or possibly others. Your doctor will go over these with you, as dosages vary from child to child. Most medications are taken orally, but growth hormone must be taken by daily injection. Your endocrinologist will work with you and your child to achieve the proper dosages and will guide you in how to administer any necessary medications. Why is it sometimes life threatening? What is adrenal insufficiency? Of the hormone deficiencies your child may have, the most critical is cortisol, also known as the 'stress hormone.' Cortisol is essential for life , and is therefore the central focus of this guide.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Disorders of the Adrenal Glands
    Disorders of the Adrenal Glands Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Physiology Cortex • Steroid hormones cortisol, aldosterone and androgens are synthesized • Derived from cholesterol • Three histologic zones – glomerulosa (aldosterone), fasiculata and reticularis Cortisol • Secretion is regulated by hypothalamus (CRH) and the pituitary (ACTH) • Exerts effects on intermediary metabolism through variety of cells and tissues • Stimulates hepatic gluconeogenesis and glycogen synthesis Cortisol • Inhibits protein synthesis, increases protein catabolism and fat lipolysis • Inhibits peripheral uptake of glucose in most tissues (liver, brain and RBCs) • Promote collagen loss and impairment of wound healing (inhibit fibroblast activity) Cortisol • Inhibit bone formation • Inhibit numerous anti-inflammatory actions • Critical for cardiovascular stability Androgens • Synthesized primarily in zona reticularis – DHEA • Peripheral conversion to testosterone and dihydrotestosterone • Account for less than 5% of normal male testosterone production Aldosterone • Regulation of ECF volume • Regulation of Na and K balance • Release is stimulated by renin through renin-angiotensin-aldosterone pathway Adrenal Medulla • Derived from neural crest cells • Principal site for catecholamine synthesis • Only site for the enzyme PNMT • Converts NE to EPI Disorders of the Adrenal Cortex Primary Hyperaldosteronism • Conn syndrome • Responsible for HTN in 8 to 12% of pts • Characterized
    [Show full text]
  • Adrenal Crisis: Still a Deadly Event in the 21St Century Troy H.K
    REVIEW Adrenal Crisis: Still a Deadly Event in the 21st Century Troy H.K. Puar, MBBS, MRCP (UK),a,b Nike M.M.L. Stikkelbroeck, MD, PhD,a Lisanne C.C.J. Smans, MD, PhD,c Pierre M.J. Zelissen, MD, PhD,c Ad. R.M.M. Hermus, MD, PhDa aDivision of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; bDepartment of Endocrinology, Changi General Hospital, Singapore; cDepartment of Internal Medicine and Endocrinology, University Medical Center Utrecht, Utrecht, The Netherlands. ABSTRACT Adrenal crisis is a life-threatening medical emergency, associated with a high mortality unless it is appropriately recognized and early treatment is rendered. Despite it being a treatable condition for almost 70 years, failure of adequate preventive measures or delayed treatment has often led to unnecessary deaths. Gastrointestinal illness is the most common precipitant for an adrenal crisis. Although most patients are educated about “sick day rules,” patients, and physicians too, are often reluctant to increase their gluco- corticoid doses or switch to parenteral injections, and thereby fail to avert the rapid deterioration of the patients’ condition. Therefore, more can be done to prevent an adrenal crisis, as well as to ensure that adequate acute medical care is instituted after a crisis has occurred. There is generally a paucity of studies on adrenal crisis. Hence, we will review the current literature, while also focusing on the incidence, pre- sentation, treatment, prevention strategies, and latest recommendations in terms of steroid dosing in stress situations. Ó 2015 Elsevier Inc. All rights reserved. The American Journal of Medicine (2015) -, --- KEYWORDS: Adrenal crisis; Adrenal insufficiency; Crisis; Emergency DEFINITION AND EPIDEMIOLOGY only if metastatic disease is bilateral, with extensive damage 4 In 1855, Thomas Addison first described patients with to the adrenal glands.
    [Show full text]
  • CANVAS Trial)
    Effectiveness research with Real World Data to support FDA’s regulatory decision making 1. RCT Details This section provides a high-level overview of the RCT that the described real-world evidence study is trying to replicate as closely as possible given the remaining limitations inherent in the healthcare databases. 1.1 Title Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes (CANVAS trial) 1.2 Intended aim(s) To compare canagliflozin to placebo on cardiovascular (CV) events including CV death, heart attack, and stroke in patients with type 2 diabetes mellitus (T2DM), whose diabetes is not well controlled at the beginning of the study and who have a history of CV events or have a high risk for CV events. 1.3 Primary endpoint for replication and RCT finding Major Adverse Cardiovascular Events, Including CV Death, Nonfatal Myocardial Infarction (MI), and Nonfatal Stroke 1.4 Required power for primary endpoint and noninferiority margin (if applicable) With 688 cardiovascular safety events recorded across the trials, there would be at least 90% power, at an alpha level of 0.05, to exclude an upper margin of the 95% confidence interval for the hazard ratio of 1.3. 1.5 Primary trial estimate targeted for replication HR = 0.86 (95% CI 0.75–0.97) comparing canagliflozin to placebo (Neal et al., 2017) 2. Person responsible for implementation of replication in Aetion Ajinkya Pawar, Ph.D. implemented the study design in the Aetion Evidence Platform. S/he is not responsible for the validity of the design and analytic choices. All implementation steps are recorded and the implementation history is archived in the platform.
    [Show full text]
  • Anemia LECTURE in INTERNAL MEDICINE for IV COURSE
    Essentials of Diagnosis, Treatment and Prevention of Major Endocrine Diseases: Diseases of the Adrenal Glands. Adrenal Insufficiency. Adrenal Hyperfunction. Hormonally Active Tumors. LECTURE IN INTERNAL MEDICINE FOR IV COURSE STUDENTS M. Yabluchansky, L. Bogun, L. Martymianova, O. Bychkova, N. Lysenko, N. Makienko V.N. Karazin National University Medical School’ Internal Medicine Dept. Plan of the Lecture • Definition • Epidemiology • Risk factors • Etiology • Mechanisms • Classification • Clinical presentation • Diagnosis • Treatment • Prognosis • Prophylaxis • Abbreviations • Diagnostic guidelines http://www.thelancet.com/pb/assets/raw/pb/assets/raw/Lancet/clinical/diseases/Cushing's.jpg http://peninsulamassage.com.au/wp-content/uploads/2012/08/Adrenal_Glands_1.jpg Definition Diseases of the Adrenal Glands • Diseases of the Adrenal Glands are conditions that interfere with the normal functioning of the adrenal glands and may cause hyperfunction (Overactive Adrenal Glands) or hypofunction (Underactive Adrenal Glands), and may be congenital or acquired. • There are two parts of the adrenal glands, the cortex, derived from mesenchymal cells, and the medulla, derived from neuroectodermal cells; first one produces mineralocorticoids, glucocorticoids, and androgens; and second one produces epinephrine (adrenaline) and norepinephrine(noradrenaline). https://en.wikipedia.org/wiki/Adrenal_gland_disorder Epidemiology Epidemiologic study of adrenal gland disorders in Japan • The total numbers of patients in Japan in 1997 were estimated as 1,450
    [Show full text]